James J. Collins
CIK: 0001779269
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SNTI
Senti Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Collins James J.
Collins James J. (SEC CIK 0001779269) files insider reports with the SEC as Director of Senti Biosciences, Inc. (SNTI).
Signal8 holds 2 ownership filings by Collins James J., all Form 4s, filed between Mar 11, 2025 and Jun 27, 2025. Those filings report 2 transactions, from Mar 7, 2025 to Jun 25, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Collins James J.'s filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Collins James J.
Other insiders filing for Senti Biosciences, Inc. (SNTI)
- Rajangam Kanya, Pres. & Chief Med. & Dev. Off.
- Lu Timothy K, CEO
- Baum Bryan Daniel, Director
- Hsiung Feng, Director
- Schulz Fran, Director
- COOPERSTONE BRENDA, Director